Directors selling on 12&18 Jan 2021 during "Off market disposal", is can understand as to bring in potential partner.
I more interesting to know who buy ELSOFT during "Off market disposal"

Why EPS same as last quarter 30.58 ?

Government for PLKS be signed for five years beginning May 23, 2015 to 22 May, 2020.

My reading is good result for Q4 :-
REVENUE PBT
Q4 10,461 3,526
Q3 9,371 3,798
VARIANCE +1,090 ( 272)
% +11.63% (7.16%)

But the losses for PBT was mainly due to as per explanation in report as per below :
(It was mainly attributed to decrease in other income by RM0.42 million of which was in
respect of gain on disposal of unquoted investment in immediate preceding quarter)

If we take out the above, the PBT was increased by +148 or 4.3%....

Revenue continues to drop for more than 5 years...
Annual report delay in publishing...No new for AGM date....
Anybody can answer the above?

I afraid is Goreng counter, to Goreng due to AGM on the way.
Otherwise, revenue no good, but the share price keeps going up, I prefer to buy safe counter.

A bit concern on SHARE price vs REVENUE
2013 = RM0.310 (as at 25 Jun 2013)
2014 = RM0.340 (as at 25 Jun 2014)
2015 = RM0.270 (as at 25 Jun 2015)
2016 = RM0.255 (as at 25 Jun 2016)
2017 = RM????? (as at 25 Jun 2017)

Why revenue keep decreasing, anyone can answer it ?
2013 = RM648,779
2014 = RM656,065
2015 = RM563,796
2016 = RM591,352
2017 = RM530,084

Revenue continue drop for 4 quarter ! Is that business slim down ?

None of the director sells their share after an announcement...I think they prefer to enjoy RM0.44 dividend instead.
I will keep and enjoying the dividend...And buy in if drop further...

Inventory increased by 3.4 times compared with the last quarter, it usually prepares for order in hand.
This forsees, next quarter sales may increase by 3.4 times....

Inari Amertron’s missed opportunity from China
TheStarFri, Mar 03, 2017

KUALA LUMPUR: AmInvestment Research views Inari Amertron (Inari) and Taiwan-based PCL Technologies’ (PCL) decision to terminate the MoU for a joint venture (JV) to provide outsourced semiconductor assembly and test (OSAT) services to major customers in China as a “missed opportunity”.

It said on Friday the announcement effectively brings an end to the long-drawn-out negotiations between Inari and PCL, which lasted for almost a year. The MoU had been extended three times over10 months.

“Although the termination does not have any financial impact on the company, it is regrettable given that the JV could have been a valuation kicker when the ‘National Guideline for the Development and Promotion of the IC Industry’ initiative in China shifts into high gear,” it said.

AmInvestment Research said the initial ambition with the JV was to focus on front-end OSAT services, with a congruent roadmap to list the business on the stock market of China within five years.

“We gather from management that the termination was on grounds that both parties were deluged with high-priority jobs currently in hand, for example, the manufacturing of iris-recognition components for Inari.

“However, the grand plan to tap into the explosive growth of China’s semiconductor industry is only put on a pause. In the future, management has said that it may very well relook into the possibility of tie-ups with PCL when the timing is right,” it said.

AmInvestment Research said it understands that Inari still owns a 9.7% stake in PCL, which gives it a slight exposure in China through PCL (Suzou) Co Ltd (PCL's China subsidiary).

It estimated that PCL contributed about RM1mil or 2% of Inari’s 1QFY17 total comprehensive income in the form of fair value increase of available-for-sale investment, which is parked under other comprehensive income before the realisation of investment.

Inari has positioned itself to capture the growth of China’s semiconductor industry through its subsidiary Amertron Technology Kunshan (ATK) in China, which manufactures LED display and infrared sensors.

“Based on our projections, ATK accounted for close to 10% of total revenue in FY16.

“All-in, while the termination is a missed opportunity for Inari, we remain positive about its prospects from the adoption of iris-recognition technology.

“We maintain our Hold call on Inari with an unchanged fair value of RM2.15 a share based on FY18F PE of 18 times, which is one standard deviation above its three-year average.

“MPI, Globetronics and Unisem are currently trading at a one-year forward PE of 11 times, 21 times and 12 times respectively,” it said.

The latest annual report status that, Fong Siling (冷眼) share held 1,200,700

RCE资本 估值仍诱人
Nanyang Sat, Nov 05, 2016

目标价：1.60令吉最新进展

RCE资本（RCECAP，9296，主板金融股）截至9月30日次季，净利表现强劲，激增80%，达1840万令吉；营业额扩大43.8%，报5616万令吉。

累计上半年，净利大涨83%，达3593万令吉；营业额则增长41.2%，报1亿809万5000令吉。

公司次季表现走强，主要是（1）利息和费用收入走高；（2）扩大贷款规模；以及

（3）消费者贷款业务支撑。

行家建议

RCE资本上半年取得的3590万令吉净利，高于我们的预期，占我们全年预测的67%。

首季的增长势头延伸到次季，这是正面迹象，净贷款按年大增16.7%，保持住首季的增速，不过，这可能是9月份佳节的因素。我们目前维持盈利预测，等待管理层最新汇报。

总债务按季上涨10%至11.9亿令吉，这是因为发售了第二批的回教债券，目前，该长期回债占总债务的22%，是正面因素，因为解决了集团资产负债失衡的问题。净负债率仍处于可管理的2.6倍水平。

由于竞争者缩减了业务，我们因而预测2017和2018财年的净贷款增长率，分别达16.3%和13.7%，主要是公务员的需求，以及市占率增长。

RCE资本的估值仍然有吸引力，2018财年的本益比仅有6.9倍。

腾达出现超卖 技术回弹中扬升3.05%
TheEdgeThu, Nov 17, 2016

（吉隆坡17日讯）券商指腾达（Pentamaster Corporation Bhd）已严重超卖，并预估其股价自10年新高位跌挫16.6%后，料很快呈技术反弹，该股今日早盘随即攀升4仙或3.05%。

然而，截至9时56分，腾达回吐部分涨幅至1.33令吉，仍上扬2仙或1.53%，成交量达59万7000股。

丰隆投资银行研究在今日的一项研究报告中指出，腾达的估值较低，其本益比（PER）为6.9倍（较同侪的11.6倍低40%），以及股价对账面价值（P/B）为2倍（较同侪的2.8倍低31%）。

该券商表示，腾达的主要支撑点介于1.24至1.29令吉，而阻力点则为1.36、1.45和1.57令吉。

“止损位为1.21令吉。”



（编译：倪嫣鴽）

This Q1 profit = 10,739K vs Last whole financial year only 8,273K, sure up.

Anybody know what happen to Mitra, fundamental good, no bad news, why drop ? anybody can tell ? or is time to accumulate this share?

Good fundamental & good future potentiality, there's opportunity to grab now.

Slow accumulating, buy again at RM0.865

Kwong Wah write-up
http://www.kwongwah.com.my/news/2014/06/19/108.html
（吉隆坡19日讯）美德再也控股有限公司（MITRA，9571，建筑组）透露，它仍然朝在截至2014年12月31日财政年为建筑部门争取15亿令吉订单的目标前进。
其现有订单企于11亿令吉。
美德再也控股董事经理陈永标称：“达到15亿令吉的目标将不会是问题，因我们已经投标总值30亿令吉左右的工程，其中我们有信心赢得至少4亿令吉。”
该集团投标的计划包括6亿令吉国家石油公司在柔佛的炼油与石化综合发展、以及同样在柔佛，价值6亿2000万令吉的奴沙再也镇建筑工程。
目前，该集团的2项最大型计划是位于布城的4亿2790万令吉反贪污委员会建筑，以及为UEM阳光有限公司（UEMS，5148，建筑组）着手在赛城Symphony Hills的共管公寓计划，总值2亿7740万令吉。
该集团也放眼在2014财政年创下5亿至6亿令吉的收益。
陈永标透露：“我们将可达到这个目标，我们现已拥有11亿令吉的订单，仅从建筑部门我们每个月即可录得3000万至4000万令吉的收益。”
该集团于截至2014年3月31日止首财季写下1亿400万令吉的收益。
在产业部门方面，陈永标表示，该集团计划在下个月杪之前，推介其于吉隆坡旺沙玛朱的豪华共管公寓发展。这项计划的总发展值达6亿5000万令吉。
“我们探讨在下月杪之前进行推介礼的可能性，而正式推介则将可能落在9或10月。”
这项计划第1期的目标认购率方面，陈永标预测，鉴于潜在买家的反应和谘询，该集团可在推介后3个月内达到70%至80%。
美德再也控股也计划明年发展坐落在雪兰莪Puchong Prima的15英亩（6.07公顷）地段为一项综合发展，发展值达15亿令吉。
“当局已给予原则上的批准，因此现在我们正落实设计。”
这项发展将包含一间5层购物广场、3栋服务公寓和一间精品酒店。
陈永标相信，对消费税实施及2014年财政预算案产业降温政策的忧虑将会克服。
他说：“产业非常依赖地点，因此当一项产业拥有良好地点和合适价格范畴，人们将会寻求买入。”
在集团归纳51%Optimax眼科中心私人有限公司的保健部门方面，陈永标指出，它目前并没有计划增加Optimax中心的数量。
“目前的中心数量已经充足。我们每年投资300万令吉资本开销，以提升我们中心的设备。”
他补充，集团的建筑与产业部门是集团收益的主流，他预期这个结构将会维持。

So many good news in June, it will back to RM0.90 & toward to RM1.00.

This is normal profit taking. I just bought RM0.88 now.